ADC	Antibody-Drug Conjugate
AI	Artificial Intelligence
AKI	Aurora Kinase Inhibitor
AI/ML	Artificial Intelligence / Machine Learning
ASCL1	Achaete-Scute Family BHLH Transcription Factor 1
AUC	Area Under the Receiver Operating Characteristic Curve
BCL2	B-Cell Lymphoma 2
BiTE	Bispecific T-Cell Engager
BTK	Bruton Tyrosine Kinase
CHK1	Checkpoint Kinase 1
C-Index	Concordance Index
CT	Computed Tomography
cfDNA	Circulating-Free DNA
ctDNA	Circulating-Tumor DNA
DNA	Deoxyribonucleic Acid
EGFR	Epidermal Growth Factor Receptor
FDA	Food and Drug Administration
GBM	Gradient Boosting Machine
GPCR	G Protein-Coupled Receptor
HER2	Human Epidermal Growth Factor Receptor 2
HR	Hazard Ratio
ISG+	Interferon-Stimulated Gene-Positive
KDR	Kinase Insert Domain Receptor (VEGFR2)
KNN	K_Nearest Neighbors
LDCT	Low-Dose Computed Tomography
LUAD	Lung Adenocarcinoma
ML	Machine Learning
MLP	Multilayer Perceptron
MET	Mesenchymal-Epithelial Transition Factor
MHC	Major Histocompatibility Complex
MYC	MYC Proto-Oncogene, BHLH Transcription Factor
NCAM1	Neural Cell Adhesion Molecule 1
NE	Neuroendocrine
NEUROD1	Neuronal Differentiation 1
NLST	National Lung Screening Trial
NMF	Non-Negative Matrix Factorization
NSCLC	Non-Small Cell Lung Cancer
OS	Overall Survival
PARP	Poly (ADP-Ribose) Polymerase
PFS	Progression Free Survival
PD-1	Programmed Cell Death Protein 1
PD-L1	Programmed Death Ligand 1
POU2F3	POU Class 2 Homeobox 3
RB1	Retinoblastoma 1
RF	Random Forest
RNA	Ribonucleic Acid
Rucaparib	Poly ADP-Ribose Polymerase Inhibitor (drug)
SCLC	Small-Cell Lung Cancer
SCLC-A	ASCL1-Driven SCLC Subtype
SCLC-N	NEUROD1-Driven SCLC Subtype
SCLC-P	POU2F3-Driven SCLC Subtype
SCLC-I	Immune-Inflamed SCLC Subtype
SEPA	Signaling Entropy for Survival Analysis
SOX2	SRY-Box Transcription Factor 2
STK11	Serine/Threonine Kinase 11
Sybil	Deep-Learning Lung Cancer Risk Prediction Model
TET2	Tet Methylcytosine Dioxygenase 2
TF	Transcription Factor
TIME	Tumor Immune Microenvironment
TKI	Tyrosine Kinase Inhibitor
TME	Tumor Microenvironment
TP53	Tumor Protein P53
T-SCLC	Transformed Small-Cell Lung Cancer
XGBoost	Extreme Gradient Boosting